Press release
Global Eosinophilic Esophagitis (EoE) Market to Witness Significant Growth Through 2030, Driven by Advancements in Diagnostics and Emerging Biologic Therapies, Reveals DelveInsight
The global Eosinophilic Esophagitis (EoE) market is expected to experience substantial growth during the forecast period 2018-2030, fueled by increasing disease awareness, advancements in diagnostic technologies, rising healthcare expenditure, and ongoing development of targeted biologic therapies. According to DelveInsight's latest report, the EoE market across the seven major markets (7MM) was valued at approximately USD 430.9 million in 2020 and is anticipated to witness significant transformation over the coming years.
Download the free sample report to explore the Eosinophilic Esophagitis market in detail: https://www.delveinsight.com/report-store/eosinophilic-esophagitis-market-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=mpr
Key Highlights From the Eosinophilic Esophagitis Market Report
The Eosinophilic Esophagitis market is projected to expand steadily through 2030 due to increasing disease prevalence, improved diagnostic capabilities, and the emergence of novel biologic therapeutic approaches aimed at enhancing efficacy and improving patient outcomes.
The market size of Eosinophilic Esophagitis across the 7MM reached approximately USD 430.9 million in 2020 and is expected to grow significantly during the forecast period 2018-2030.
Key companies operating in the Eosinophilic Esophagitis market include Takeda/Shire, Bristol-Myers Squibb, Regeneron Pharmaceuticals/Sanofi, AstraZeneca, Allakos, and Ellodi Pharmaceuticals, among other major therapeutics providers.
The report highlights increasing research efforts focused on improving treatment efficacy, developing targeted biologic therapies, and optimizing treatment algorithms combining diet, drugs, and dilation ("3Ds").
Ongoing developments in biologic immunotherapies, anti-inflammatory agents, and enhanced diagnostic methodologies are expected to reshape the EoE treatment landscape in the coming years.
Understanding Eosinophilic Esophagitis (EoE)
Eosinophilic Esophagitis (EoE) is a chronic, local immune-mediated esophageal disease clinically and histologically characterized by symptoms related to esophageal dysfunction and eosinophil-predominant inflammation. It is a distinct disease entity that was first described in 1978, misinterpreted as achalasia, and formally recognized as a distinct condition more than a decade later.
The disease is characterized by major symptoms including heartburn, regurgitation, esophageal stenosis, and dysphagia, with greater prevalence in young adults and children. Established risk factors include male gender, Caucasian race, and atopy, with genetic predisposition supported by family clustering and specific genetic polymorphisms.
The pathophysiology of EoE is complex, involving a network of various cells and molecules including eosinophils, Th2 cells, thymic stromal lymphopoietin (TSLP), transforming growth factor-beta 1 (TGF-1), and interleukin-13 (IL-13). Environmental factors, including the timing and nature of food and aeroallergen exposure during immune system development, contribute significantly to disease manifestation.
Access a free sample PDF to explore the EoE therapeutic landscape: Eosinophilic Esophagitis Epidemiology Insights [https://www.delveinsight.com/report-store/eosinophilic-esophagitis-market-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=mpr]
Eosinophilic Esophagitis (EoE) Epidemiology Insights
The epidemiology section of the report provides detailed historical and forecasted trends of EoE across the seven major markets from 2018 to 2030.
Key epidemiological insights include:
*
Total diagnosed prevalent cases of EoE in the 7MM
*
Gender-specific diagnosed prevalent cases
*
Age-specific diagnosed prevalent cases
*
Country-wise epidemiological analysis across the United States, EU5, and Japan
The report enables stakeholders to better understand disease burden, patient demographics, and evolving epidemiological trends supporting strategic planning and commercial decision-making.
The report offers a detailed overview of current diagnostic and treatment practices for EoE: https://www.delveinsight.com/report-store/eosinophilic-esophagitis-market-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=mpr
Diagnosis
Diagnostic approaches covered in the report include:
*
Endoscopic evaluation
*
Histological examination (requiring greater than or equal to 15 eosinophils per high-power field for confirmation)
*
Identification of endoscopic features (linear grooves, concentric rings, whitish exudates, Schatzki rings)
*
Esophageal mucosal biopsy analysis
*
Assessment of esophageal narrowing and strictures
Advancements in endoscopic imaging and standardized histological criteria are improving early detection and disease monitoring capabilities.
Treatment
The treatment landscape analysis includes the fundamental "3D" treatment concept:
Dietary Management:
*
Empirical food elimination diets
*
Guided food elimination based on allergy testing
*
Dietary modification to avoid dysphagia and food impaction
Pharmacologic Therapy:
*
Proton pump inhibitors (PPIs) as first-line treatment with response rates of 30-70%
*
Corticosteroid formulations including budesonide, fluticasone propionate, and ciclesonide
*
Immunosuppressive agents
*
Novel targeted biologic therapies
Mechanical Intervention:
*
Endoscopic bougie dilation
*
Balloon dilation for esophageal strictures
*
Periodic dilation as acceptable alternative therapy
Regional treatment guidelines and algorithms across the US, Europe, and Japan are provided to support standardized clinical decision-making.
Eosinophilic Esophagitis (EoE) Drug Chapters
The report provides comprehensive analysis of marketed products and emerging pipeline therapies under development for EoE treatment.
Marketed Therapies
The report covers currently available therapies and treatment options utilized in clinical practice for EoE management, including proton pump inhibitors, topical corticosteroids, and endoscopic dilation procedures.
Emerging Therapies
Budesonide Oral Suspension (Takeda/Shire) An oral viscous formulation of budesonide formulated specifically as an investigational treatment for EoE. Clinical trials demonstrate this formulation is more effective than nebulized or swallowed budesonide for improving esophageal eosinophil counts and endoscopic findings in adults. The US FDA has granted priority review, breakthrough therapy designation, and orphan designation. The company submitted a new drug application (NDA) based on pivotal Phase III trials ORBIT1 and ORBIT2, with additional Phase III continuation studies underway for adolescent and adult subjects.
Cendakimab (Bristol-Myers Squibb) A recombinant humanized, high-affinity, selective anti-interleukin-13 (IL-13) monoclonal antibody that binds an IL-13 epitope preventing its binding to both IL-13 receptor subtypes. The drug has been granted orphan drug designation for EoE treatment. Phase II studies demonstrated positive results, and Phase III clinical trials are currently evaluating efficacy and safety in adult and adolescent participants.
The pipeline section also evaluates additional late-stage and mid-stage therapies including:
*
Dupilumab (Regeneron Pharmaceuticals/Sanofi)
*
APT-1011 (Ellodi Pharmaceuticals)
*
Benralizumab (AstraZeneca)
*
Lirentelimab (Allakos)
The report further analyzes:
*
Clinical trial activities and endpoints
*
Pharmacological mechanisms of action
*
Licensing and collaboration agreements
*
Patent and regulatory developments
*
Recent company updates and strategic initiatives
Eosinophilic Esophagitis (EoE) Market Outlook
The Eosinophilic Esophagitis market outlook section delivers detailed insights into current and forecasted market trends by evaluating:
*
Existing and emerging therapies
*
Unmet clinical needs
*
Market drivers and barriers
*
Therapy-specific uptake trends
*
Competitive positioning of marketed and pipeline products
The report also assesses annual therapy costs, expected launch timelines, patient eligibility criteria, market penetration potential, and key opinion leader perspectives influencing future adoption trends.
According to DelveInsight, the Eosinophilic Esophagitis market across the 7MM is anticipated to undergo significant transformation during the forecast period 2018-2030.
Regional Eosinophilic Esophagitis Market OutlookUnited States Market Outlook
This section provides detailed analysis of the total EoE market size and therapy-specific market trends in the United States. The United States accounts for the highest market size of EoE in comparison to the EU5 countries and Japan. The market analysis includes:
*
PPIs as first-line treatment with initial doses of 20-40 mg or 1 mg/kg per dose administered twice daily
*
Corticosteroid efficacy in achieving histological remission
*
Bougie and balloon dilation as the only endoscopic treatment for persistent dysphagia
*
Current and forecasted therapy adoption trends
EU5 Market Outlook
Comprehensive market analysis is provided for Germany, France, Italy, Spain, and the United Kingdom, covering:
*
Current and forecasted therapy adoption trends
*
Regional variations in treatment approaches
*
Market dynamics and competitive landscape
Japan Market Outlook
The report also evaluates the EoE market dynamics and therapy landscape in Japan, providing insights specific to the Japanese healthcare system and treatment practices.
Eosinophilic Esophagitis (EoE) Drugs Uptake and Pipeline Development Activities
The report evaluates the expected uptake of recently launched and upcoming therapies during the study period 2018-2030. The analysis focuses on:
*
Patient uptake trends by therapy type
*
Therapy adoption rates across regions
*
Market share analysis
*
Commercial potential of pipeline candidates
*
Reasons behind maximal use of new drugs
*
Comparison of drugs based on market share and size
Additionally, the report highlights:
*
Phase III, Phase II/III, Phase II, and Phase I/II pipeline candidates
*
Collaborations and licensing agreements
*
Mergers and acquisitions
*
Patent activities
*
Strategic partnerships influencing market expansion
*
Key players involved in developing targeted therapeutics
Reimbursement Scenario in Eosinophilic Esophagitis (EoE)
The report provides valuable reimbursement insights supporting strategic market access planning. It evaluates pricing and reimbursement challenges across key geographies while identifying commercially attractive markets with lower reimbursement barriers and favorable payer policies.
KOL Views and Competitive Intelligence Analysis
To validate secondary research findings and assess evolving treatment trends, DelveInsight incorporates perspectives from key opinion leaders (KOLs) and subject matter experts working in the EoE domain. These insights support understanding of current and emerging therapy treatment patterns and market trends.
The report also includes extensive competitive intelligence analysis utilizing tools such as:
*
SWOT Analysis
*
PESTLE Analysis
*
Porter's Five Forces
*
BCG Matrix
*
Market Entry Strategies
These insights support stakeholders in identifying future opportunities and competitive positioning within the evolving market landscape.
Eosinophilic Esophagitis (EoE) Market Drivers and ChallengesKey Market Drivers
*
Increasing awareness and diagnosis of EoE
*
Rising prevalence of immune-mediated esophageal disorders
*
Advancements in endoscopic diagnostics and standardized histological criteria
*
Growing healthcare expenditure globally
*
Unmet clinical need for FDA-approved targeted therapies
*
Emerging biologic therapies offering improved efficacy
*
Rising incidence in young adults and children
*
Increasing research into improved treatment algorithms
Key Market Challenges
*
Lack of FDA-approved drugs specifically for EoE treatment
*
Variability in treatment response and disease natural history
*
Complexity of the "3D" treatment approach requiring multidisciplinary management
*
Limited uniform endpoints in clinical trials
*
Recurrence and relapse risks requiring long-term maintenance therapy
*
Need for deeper understanding of disease progression
*
Reimbursement and pricing challenges for emerging biologic therapies
*
Regional variations in treatment guidelines and practices
Download sample report now - https://www.delveinsight.com/report-store/eosinophilic-esophagitis-market-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=mpr
Eosinophilic Esophagitis (EoE) Report Scope
The report offers global coverage with focus on:
*
Historical and forecasted market trends from 2018 to 2030
*
Epidemiology analysis across the 7MM
*
Current and emerging therapies
*
Competitive landscape and pipeline assessment
*
Market drivers, barriers, and unmet needs
*
Strategic insights for stakeholders and healthcare companies
*
Detailed disease understanding and treatment algorithms
*
Comprehensive KOL perspectives and competitive intelligence
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharmaceutical and biotechnology companies by providing comprehensive end-to-end solutions to improve business performance and strategic decision-making.
Media Contact
Company Name: DelveInsight
Contact Person: Mehul Malhotra
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=global-eosinophilic-esophagitis-eoe-market-to-witness-significant-growth-through-2030-driven-by-advancements-in-diagnostics-and-emerging-biologic-therapies-reveals-delveinsight]
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: https://www.delveinsight.com/
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Eosinophilic Esophagitis (EoE) Market to Witness Significant Growth Through 2030, Driven by Advancements in Diagnostics and Emerging Biologic Therapies, Reveals DelveInsight here
News-ID: 4534344 • Views: …
More Releases from ABNewswire
How to Choose a Garden Tool Set for Export Quality Standards
Why the Right Garden Tool Set Matters
The global horticultural equipment market demands high-performance hand tools, making the procurement of a reliable garden tool set a critical strategic decision for importers, wholesalers, and large-scale distributors. Selecting tools that meet strict export quality standards ensures product longevity, protects brand reputation in competitive retail landscapes, and guarantees compliance with stringent regional regulations. A meticulously sourced tool set minimizes downstream liabilities and maximizes retail…
Why Choose Membrane Disc Diffuser for Efficient Aeration?
When you're trying to find the best way to get some efficient aeration going, picking the right technology really makes all the difference. You might have heard about the Membrane Disc Diffuser [https://www.juntaienviro.com/membrane-disc-diffuser/]- it's become pretty popular in wastewater Treatment Plants [https://www.juntaienviro.com/treatment-plants/] these days, mainly because it performs so well. According to a report from the EPA, aeration can actually eat up to 60% of the energy costs in these…
Why is Surface Cleaning Essential for Global Supply Chains?
In today's super-connected world, the efficiency of global supply chains really depends on a bunch of different factors. One thing that's often overlooked but super important is Surface Cleaning [https://www.8waterhk.com/surface-cleaning/]. According to Dr. Jane Smith from CleanTech Solutions, it's not just about making things look shiny-"Surface Cleaning [https://www.8waterhk.com/surface-cleaning/] is about keeping products safe and intact all along the supply chain." Makes sense, right? It's a key piece of the puzzle…
What is Brushed Finish? Industry Trends and Best Practices
In the field of stainless steel CNC machining [https://www.lvma-cnc.com/cnc-machining-service/], surface treatment processes directly influence a product's visual appeal and perceived quality. Among the numerous available processing techniques, the wire-drawing process offers a unique texture and tactile feel; it is frequently employed for mobile phone mid-frames as a solution to enhance the product's overall sophistication.
I will introduce the principles, processing requirements, and different types of the brushed finish to help you…
More Releases for EoE
Eosinophilic Esophagitis (EoE) Market Landscape, Future Growth Opportunities, Tr …
Eosinophilic Esophagitis (EoE) is a chronic, immune-mediated inflammatory condition of the esophagus characterized by eosinophil accumulation in the esophageal tissue. It causes dysphagia, food impaction, chest pain, and feeding difficulties, often leading to significant quality-of-life impairment.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71111
The incidence of EoE has been rising globally, particularly in developed countries, linked to changing lifestyles, food allergies, and increased recognition of the disease through improved…
Easy Open End (Eoe) Market to Witness Stunning Growth with Baosteel, AluStar, Si …
HTF MI recently introduced Global Easy Open End (Eoe) Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2024-2032). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence. Some key players from the complete study are Crown Holdings, Silgan Holdings, Ardagh Group, Can-Pack, CPMC Holdings, Easy Open…
Eosinophilic Esophagitis (EoE) Treatment Market Size, Share, Growth and Trends, …
Eosinophilic esophagitis (EoE) is a chronic immune-related disorder affecting the digestive system, where a high number of white blood cells called eosinophils build up in the esophagus, leading to inflammation. It's often linked to food allergies as a potential cause. Common symptoms include vomiting, stomach or chest pain, difficulty swallowing, food getting stuck in the throat, and in children, failure to thrive or grow properly.
Get a Free Sample Research PDF…
Customized Services at Hualong EOE: Redefining Excellence in the Global Metal Pa …
EOE products [https://www.hualongeoe.com/]with customized services stand out for diverse application ability with precision and efficiency in metal packaging industry. Whether for food or non-food products, these solutions are tailored to accommodate specific needs such as can end diameters, label printing, and opening features, which ensures that each EOE not only enhances can accessibility but also reinforces brand identity and consumer trust.
Beyond functionality, customized EOE solutions prioritize consumer experience with innovation…
Eosinophilic Esophagitis Market - From Diagnosis to Remission: Comprehensive Sup …
Newark, New Castle, USA: The "Eosinophilic Esophagitis Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Eosinophilic Esophagitis Market: https://www.growthplusreports.com/report/eosinophilic-esophagitis-market/8513
This latest report researches the industry structure, sales, revenue,…
Global Easy Open Ends (EOE) Market Status Report COVID 19 Impact Analysis
Market Overview
The Easy Open Ends (EOE) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Easy Open Ends (EOE) market size is expected to gain market growth in the forecast…
